A Phase II Trial of a WT-1 Vaccine in Patients with Acute Myeloid Leukemia
[Protocol 10-143] |
Maslak, Peter |
- Leukemia
- Acute Myelogenous Leukemia
|
A Phase II Toxicity Study Using Chemotherapy Followed By Intensity Modulated Radiation Therapy to the Pleura in Patients with Locally Advanced Unresectable Malignant Pleural Mesothelioma
[Protocol 08-053] |
Krug, Lee |
|
A Phase II Study of WT-1 Analog Peptide Vaccine in Patients with Malignant Pleural Mesothelioma
[Protocol 10-134] |
Krug, Lee |
|
A Phase II Study of Vorinostat for Metastatic Uveal Melanoma
[Protocol 12-027] |
Carvajal, Richard |
|
A Phase II Study of Vemurafenib in Patients with Relapsed or Refractory Hairy Cell Leukemia
[Protocol 12-200] |
Park, Jae |
|
A Phase II Study of Vemurafenib in Patients with BRAF V600 Mutation-Positive Cancers
[Protocol 12-131] |
Hyman, David |
- Hematology
- Hematologic Disorders
- Multiple Myeloma
|
A Phase II Study of Veliparib plus Temozolomide, Veliparib plus Carboplatin and Paclitaxel, or Carboplatin and Paclitaxel with Placebo in Patients with BRCA Mutations and Metastatic Breast Cancer
[Protocol 12-122] |
Robson, Mark |
|
A Phase II Study of Tretinoin plus Arsenic Trioxide in Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Therapy
[Protocol 11-040] |
Park, Jae |
- Leukemia
- Acute Myelogenous Leukemia
|
A Phase II Study of Trebananib (AMG 386) for the Treatment of Inoperable Advanced Angiosarcoma
[Protocol 12-128] |
D'Angelo, Sandra |
|
A Phase II Study of Temozolomide plus Irinotecan with or without Bevacizumab in Children with Recurrent or Refractory Medulloblastoma or PNET
[Protocol 11-089] |
De Braganca, Kevin |
|
A Phase II Study of Temozolomide Alone or with ABT-888 (Veliparib) in Patients with Relapsed or Refractory Small Cell Lung Cancer
[Protocol 12-021] |
Pietanza, M. Catherine |
- Lung Cancer
- Lung Cancer, Small Cell
|
A Phase II Study of Sunitinib to Treat High-Grade Glioma and Ependymoma Tumors in Pediatric and Young Adult Patients
[Protocol 13-026] |
Khakoo, Yasmin |
- Brain Tumors, Primary
- Pediatric Brain Tumors
|
A Phase II Study of Sunitinib or Cediranib for Inoperable Metastatic Alveolar Soft Part Sarcoma
[Protocol 12-095] |
Keohan, Mary |
|
A Phase II Study of Sorafenib plus Doxorubicin in Patients with Liver Cancer that Continued Growing with Sorafenib Therapy
[Protocol 12-259] |
Abou-Alfa, Ghassan |
|
A Phase II Study of Sorafenib in Children and Young Adults with Relapsed/Refractory Rhabdomyosarcoma, Wilms Tumor, Hepatocellular Carcinoma, or Papillary Thyroid Cancer
[Protocol 12-139] |
Trippett, Tanya |
- Hepatobiliary
- Kidney Cancer
- Sarcomas
- Thyroid Cancer
|
A Phase II Study of Siltuximab in Patients with High-Risk Smoldering Multiple Myeloma
[Protocol 12-068] |
Lesokhin, Alexander |
|
A Phase II Study of Secondary Cytoreduction with and without HIPEC plus Postoperative Chemotherapy for Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-275] |
Chi, Dennis |
|
A Phase II Study of Response-Based Radiation Therapy for Patients with Localized Germ Cell Tumors of the Central Nervous System
[Protocol 12-243] |
Dunkel, Ira |
- Germ Cell Tumors
- Pediatric Brain Tumors
|
A Phase II Study of Repeat Breast-Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation for Local Recurrence of Breast Cancer
[Protocol 10-152] |
McCormick, Beryl |
|
A Phase II Study of Reduced-Intensity Allogeneic Stem Cell Transplant for High-Risk Chronic Lymphocytic Leukemia
[Protocol 11-024] |
Perales, Miguel-Angel |
- Blood and Marrow Transplantation
- Leukemia
- Chronic Lymphocytic Leukemia
|
